首页> 外国专利> LENTIVIRAL VECTOR THTD, AGING AGENT, CANCER INHIBITOR, AND MEDICINAL COMPOSITION CONTAINING SAID THTD, PROTEIN PACKAGED IN VIRUSLIKE HOLLOW PARTICLE, AND PRODUCTION METHOD FOR VIRUSLIKE HOLLOW PARTICLE

LENTIVIRAL VECTOR THTD, AGING AGENT, CANCER INHIBITOR, AND MEDICINAL COMPOSITION CONTAINING SAID THTD, PROTEIN PACKAGED IN VIRUSLIKE HOLLOW PARTICLE, AND PRODUCTION METHOD FOR VIRUSLIKE HOLLOW PARTICLE

机译:病毒样空心颗粒中的慢病毒载体,衰老剂,癌症抑制剂和药物组合物,病毒样空心颗粒中包装的蛋白质以及生产该病毒样空心颗粒的方法

摘要

The purpose of the present invention is to pinpoint the fundamental causes that generate abnormalities in the cell cycle and to eliminate said causes on the upstream side of the occurrence of abnormal conditions so as to effectively and definitively inhibit abnormalities in the cell cycle and the occurrence of cancers generated thereby. The present invention is a lentiviral vector THTD, and a human breast cancer MCF7 cell aging agent, a cancer inhibitor, and a medicinal composition that contain the lentiviral vector THTD. The lentiviral vector THTD can produce a CDC6 shRNA that is a short hairpin RNA against human CDC6 mRNA by means of gene transfer into an infected cell.
机译:本发明的目的是查明在细胞周期中产生异常的根本原因,并在异常情况发生的上游侧消除所述原因,从而有效地,绝对地抑制细胞周期中异常的发生。由此产生的癌症。本发明是一种慢病毒载体THTD,以及包含该慢病毒载体THTD的人乳腺癌MCF7细胞老化剂,癌症抑制剂和药物组合物。慢病毒载体THTD可通过将基因转移到感染细胞中而产生CDC6 shRNA,该CDC6 shRNA是针对人类CDC6 mRNA的短发夹RNA。

著录项

  • 公开/公告号WO2015020215A1

    专利类型

  • 公开/公告日2015-02-12

    原文格式PDF

  • 申请/专利权人 NAGATA KEIJI;HIROTA TAKESHI;

    申请/专利号WO2014JP71101

  • 发明设计人 ARAI TAKAAKI;

    申请日2014-08-08

  • 分类号C12N15/09;A61K48;A61P35;

  • 国家 WO

  • 入库时间 2022-08-21 15:08:19

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号